Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Berginer

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of the History of the Neurosciences|June 1, 1995
Historical aspects of cerebrotendinous xanthomatosis (CTX)V M Berginer
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1992
[Cerebrotendinous xanthomatosis]V M Berginer
Neurology|July 1, 1992
Neurodegenerative disordersV M Berginer
The Israel Medical Association Journal : IMAJ|November 4, 2000
Neurological aspects of the David-Goliath battle: restriction in the giant's visual fieldV M Berginer
Neurologia I Neurochirurgia Polska|January 1, 1996
Aspects of cerebrotendinous xanthomatosis (CTX)V M Berginer
European Journal of Clinical Microbiology|June 1, 1987
Acquisition of tetanus in the desertV M Berginer, M Alkan
Journal of the Neurological Sciences|February 1, 1994
LDL-apheresis cannot be recommended for treatment of cerebrotendinous xanthomatosisV M Berginer, G Salen
American Journal of Medical Genetics|January 1, 1981
Genetics of cerebrotendinous xanthomatosis (CTX): an autosomal recessive trait with high gene frequency in Sephardim of Moroccan originV M Berginer, D Abeliovich
Harefuah|August 1, 1986
[Neurological manifestations of acquired immunodeficiency syndrome]V M Berginer, M Alkan
The New England Journal of Medicine|December 27, 1984
Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acidV M Berginer, G Salen, S Shefer
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of the History of the Neurosciences|June 1, 1995
Historical aspects of cerebrotendinous xanthomatosis (CTX)V M Berginer
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1992
[Cerebrotendinous xanthomatosis]V M Berginer
Neurology|July 1, 1992
Neurodegenerative disordersV M Berginer
The Israel Medical Association Journal : IMAJ|November 4, 2000
Neurological aspects of the David-Goliath battle: restriction in the giant's visual fieldV M Berginer
Neurologia I Neurochirurgia Polska|January 1, 1996
Aspects of cerebrotendinous xanthomatosis (CTX)V M Berginer
European Journal of Clinical Microbiology|June 1, 1987
Acquisition of tetanus in the desertV M Berginer, M Alkan
Journal of the Neurological Sciences|February 1, 1994
LDL-apheresis cannot be recommended for treatment of cerebrotendinous xanthomatosisV M Berginer, G Salen
American Journal of Medical Genetics|January 1, 1981
Genetics of cerebrotendinous xanthomatosis (CTX): an autosomal recessive trait with high gene frequency in Sephardim of Moroccan originV M Berginer, D Abeliovich
Harefuah|August 1, 1986
[Neurological manifestations of acquired immunodeficiency syndrome]V M Berginer, M Alkan
The New England Journal of Medicine|December 27, 1984
Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acidV M Berginer, G Salen, S Shefer
Pageof 4